1. AB0778 ASSOCIATION BETWEEN PATIENT-REPORTED OUTCOMES AND DISEASE ACTIVITY IN BIMEKIZUMAB-TREATED PATIENTS WITH PSORIATIC ARTHRITIS. (2nd June 2020) Authors: Gossec, L.; Mease, P. J.; Gottlieb, A. B.; Ogdie, A.; Assudani, D.; Coarse, J.; Ink, B.; Coates, L. C. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SAT0403 EFFICACY AND SAFETY OF 108 WEEKS' BIMEKIZUMAB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS: INTERIM RESULTS FROM A PHASE 2 OPEN-LABEL EXTENSION STUDY. (2nd June 2020) Authors: Mcinnes, I.; Merola, J. F.; Mease, P. J.; Coates, L. C.; Joshi, P.; Coarse, J.; Ink, B.; Ritchlin, C. T. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗